提巴因
化学
生物化学
酵母
生物合成
酶
吗啡
生物
药理学
可待因
作者
Natali Özber,Lisa Yu,Jillian M. Hagel,Peter J. Facchini
标识
DOI:10.1021/acschembio.2c00873
摘要
Systematic screening of morphine pathway intermediates in engineered yeast revealed key biosynthetic enzymes displaying potent feedback inhibition: 3′-hydroxy-N-methylcoclaurine 4′-methyltransferase (4′OMT), which yields (S)-reticuline, and the coupled salutaridinol-7-O-acetyltransferase (SalAT) and thebaine synthase (THS2) enzyme system that produces thebaine. The addition of deuterated reticuline-d1 to a yeast strain able to convert (S)-norcoclaurine to (S)-reticuline showed reduced product accumulation in response to the feeding of all four successive pathway intermediates. Similarly, the addition of deuterated thebaine-d3 to a yeast strain able to convert salutaridine to thebaine showed reduced product accumulation from exogenous salutaridine or salutaridinol. In vitro analysis showed that reticuline is a noncompetitive inhibitor of 4′OMT, whereas thebaine exerts mixed inhibition on SalAT/THS2. In a yeast strain capable of de novo morphine biosynthesis, the addition of reticuline and thebaine resulted in the accumulation of several pathway intermediates. In contrast, morphine had no effect, suggesting that circumventing the interaction of reticuline and thebaine with 4′OMT and SalAT/THS2, respectively, could substantially increase opiate alkaloid titers in engineered yeast.
科研通智能强力驱动
Strongly Powered by AbleSci AI